A Multi-Center, Phase Ib Study of Subcutaneous Administration of Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma
Haematologica(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要